Influence of SGLT2 Inhibitors in Remodeling, Substrate and Ion Metabolism of Myocardium to Prevent Cardiovascular Risks: Recent Work and Advancement

Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.Z.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.; Catapano, A.L.; Chugh, S.S.; Cooper, L.T.; Coresh, J.; Criqui, M.; DeCleene, N.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Solà, J.; Fowkes, G.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.; Koroshetz, W.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Temesgen, A.M.; Mokdad, A.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Moraes de Oliveira, G.; Otto, C.; Owolabi, M.; Pratt, M.; Rajagopalan, S.; Reitsma, M.; Ribeiro, A.L.P.; Rigotti, N.; Rodgers, A.; Sable, C.; Shakil, S.; Sliwa-Hahnle, K.; Stark, B.; Sundström, J.; Timpel, P.; Tleyjeh, I.M.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.; Murray, C.; Fuster, V.; Roth, G.A.; Mensah, G.A.; Johnson, C.O.; Addolorato, G.; Ammirati, E.; Baddour, L.M.; Barengo, N.C.; Beaton, A.; Benjamin, E.J.; Benziger, C.P.; Bonny, A.; Brauer, M.; Brodmann, M.; Cahill, T.J.; Carapetis, J.R.; Catapano, A.L.; Chugh, S.; Cooper, L.T.; Coresh, J.; Criqui, M.H.; DeCleene, N.K.; Eagle, K.A.; Emmons-Bell, S.; Feigin, V.L.; Fernández-Sola, J.; Fowkes, F.G.R.; Gakidou, E.; Grundy, S.M.; He, F.J.; Howard, G.; Hu, F.; Inker, L.; Karthikeyan, G.; Kassebaum, N.J.; Koroshetz, W.J.; Lavie, C.; Lloyd-Jones, D.; Lu, H.S.; Mirijello, A.; Misganaw, A.T.; Mokdad, A.H.; Moran, A.E.; Muntner, P.; Narula, J.; Neal, B.; Ntsekhe, M.; Oliveira, G.M.M.; Otto, C.M.; Owolabi, M.O.; Pratt, M.; Rajagopalan, S.; Reitsma, M.B.; Ribeiro, A.L.P.; Rigotti, N.A.; Rodgers, A.; Sable, C.A.; Shakil, S.S.; Sliwa, K.; Stark, B.A.; Sundström, J.; Timpel, P.; Tleyjeh, I.I.; Valgimigli, M.; Vos, T.; Whelton, P.K.; Yacoub, M.; Zuhlke, L.J.; Abbasi-Kangevari, M.; Abdi, A.; Abedi, A.; Aboyans, V.; Abrha, W.A.; Abu-Gharbieh, E.; Abushouk, A.I.; Acharya, D.; Adair, T.; Adebayo, O.M.; Ademi, Z.; Advani, S.M.; Afshari, K.; Afshin, A.; Agarwal, G.; Agasthi, P.; Ahmad, S.; Ahmadi, S.; Ahmed, M.B.; Aji, B.; Akalu, Y.; Akande-Sholabi, W.; Aklilu, A.; Akunna, C.J.; Alahdab, F.; Al-Eyadhy, A.; Alhabib, K.F.; Alif, S.M.; Alipour, V.; Aljunid, S.M.; Alla, F.; Almasi-Hashiani, A.; Almustanyir, S.; Al-Raddadi, R.M.; Amegah, A.K.; Amini, S.; Aminorroaya, A.; Amu, H.; Amugsi, D.A.; Ancuceanu, R.; Anderlini, D.; Andrei, T.; Andrei, C.L.; Ansari-Moghaddam, A.; Anteneh, Z.A.; Antonazzo, I.C.; Antony, B.; Anwer, R.; Appiah, L.T.; Arabloo, J.; Ärnlöv, J.; Artanti, K.D.; Ataro, Z.; Ausloos, M.; Avila-Burgos, L.; Awan, A.T.; Awoke, M.A.; Ayele, H.T.; Ayza, M.A.; Azari, S. B, D.B.; Baheiraei, N.; Baig, A.A.; Bakhtiari, A.; Banach, M.; Banik, P.C.; Baptista, E.A.; Barboza, M.A.; Barua, L.; Basu, S.; Bedi, N.; Béjot, Y.; Bennett, D.A.; Bensenor, I.M.; Berman, A.E.; Bezabih, Y.M.; Bhagavathula, A.S.; Bhaskar, S.; Bhattacharyya, K.; Bijani, A.; Bikbov, B.; Birhanu, M.M.; Boloor, A.; Brant, L.C.; Brenner, H.; Briko, N.I.; Butt, Z.A.; Caetano dos Santos, F.L.; Cahill, L.E.; Cahuana-Hurtado, L.; Cámera, L.A.; Campos-Nonato, I.R.; Cantu-Brito, C.; Car, J.; Carrero, J.J.; Carvalho, F.; Castañeda-Orjuela, C.A.; Catalá-López, F.; Cerin, E.; Charan, J.; Chattu, V.K.; Chen, S.; Chin, K.L.; Choi, J.Y.J.; Chu, D.T.; Chung, S.C.; Cirillo, M.; Coffey, S.; Conti, S.; Costa, V.M.; Cundiff, D.K.; Dadras, O.; Dagnew, B.; Dai, X.; Damasceno, A.A.M.; Dandona, L.; Dandona, R.; Davletov, K.; De la Cruz-Góngora, V.; De la Hoz, F.P.; De Neve, J.W.; Denova-Gutiérrez, E.; Derbew Molla, M.; Derseh, B.T.; Desai, R.; Deuschl, G.; Dharmaratne, S.D.; Dhimal, M.; Dhungana, R.R.; Dianatinasab, M.; Diaz, D.; Djalalinia, S.; Dokova, K.; Douiri, A.; Duncan, B.B.; Duraes, A.R.; Eagan, A.W.; Ebtehaj, S.; Eftekhari, A.; Eftekharzadeh, S.; Ekholuenetale, M.; El Nahas, N.; Elgendy, I.Y.; Elhadi, M.; El-Jaafary, S.I.; Esteghamati, S.; Etisso, A.E.; Eyawo, O.; Fadhil, I.; Faraon, E.J.A.; Faris, P.S.; Farwati, M.; Farzadfar, F.; Fernandes, E.; Fernandez Prendes, C.; Ferrara, P.; Filip, I.; Fischer, F.; Flood, D.; Fukumoto, T.; Gad, M.M.; Gaidhane, S.; Ganji, M.; Garg, J.; Gebre, A.K.; Gebregiorgis, B.G.; Gebregzabiher, K.Z.; Gebremeskel, G.G.; Getacher, L.; Obsa, A.G.; Ghajar, A.; Ghashghaee, A.; Ghith, N.; Giampaoli, S.; Gilani, S.A.; Gill, P.S.; Gillum, R.F.; Glushkova, E.V.; Gnedovskaya, E.V.; Golechha, M.; Gonfa, K.B.; Goudarzian, A.H.; Goulart, A.C.; Guadamuz, J.S.; Guha, A.; Guo, Y.; Gupta, R.; Hachinski, V.; Hafezi-Nejad, N.; Haile, T.G.; Hamadeh, R.R.; Hamidi, S.; Hankey, G.J.; Hargono, A.; Hartono, R.K.; Hashemian, M.; Hashi, A.; Hassan, S.; Hassen, H.Y.; Havmoeller, R.J.; Hay, S.I.; Hayat, K.; Heidari, G.; Herteliu, C.; Holla, R.; Hosseini, M.; Hosseinzadeh, M.; Hostiuc, M.; Hostiuc, S.; Househ, M.; Huang, J.; Humayun, A.; Iavicoli, I.; Ibeneme, C.U.; Ibitoye, S.E.; Ilesanmi, O.S.; Ilic, I.M.; Ilic, M.D.; Iqbal, U.; Irvani, S.S.N.; Islam, S.M.S.; Islam, R.M.; Iso, H.; Iwagami, M.; Jain, V.; Javaheri, T.; Jayapal, S.K.; Jayaram, S.; Jayawardena, R.; Jeemon, P.; Jha, R.P.; Jonas, J.B.; Jonnagaddala, J.; Joukar, F.; Jozwiak, J.J.; Jürisson, M.; Kabir, A.; Kahlon, T.; Kalani, R.; Kalhor, R.; Kamath, A.; Kamel, I.; Kandel, H.; Kandel, A.; Karch, A.; Kasa, A.S.; Katoto, P.D.M.C.; Kayode, G.A.; Khader, Y.S.; Khammarnia, M.; Khan, M.S.; Khan, M.N.; Khan, M.; Khan, E.A.; Khatab, K.; Kibria, G.M.A.; Kim, Y.J.; Kim, G.R.; Kimokoti, R.W.; Kisa, S.; Kisa, A.; Kivimäki, M.; Kolte, D.; Koolivand, A.; Korshunov, V.A.; Koulmane Laxminarayana, S.L.; Koyanagi, A.; Krishan, K.; Krishnamoorthy, V.; Kuate Defo, B.; Kucuk Bicer, B.; Kulkarni, V.; Kumar, G.A.; Kumar, N.; Kurmi, O.P.; Kusuma, D.; Kwan, G.F.; La Vecchia, C.; Lacey, B.; Lallukka, T.; Lan, Q.; Lasrado, S.; Lassi, Z.S.; Lauriola, P.; Lawrence, W.R.; Laxmaiah, A.; LeGrand, K.E.; Li, M-C.; Li, B.; Li, S.; Lim, S.S.; Lim, L.L.; Lin, H.; Lin, Z.; Lin, R.T.; Liu, X.; Lopez, A.D.; Lorkowski, S.; Lotufo, P.A.; Lugo, A.; M, N.K.; Madotto, F.; Mahmoudi, M.; Majeed, A.; Malekzadeh, R.; Malik, A.A.; Mamun, A.A.; Manafi, N.; Mansournia, M.A.; Mantovani, L.G.; Martini, S.; Mathur, M.R.; Mazzaglia, G.; Mehata, S.; Mehndiratta, M.M.; Meier, T.; Menezes, R.G.; Meretoja, A.; Mestrovic, T.; Miazgowski, B.; Miazgowski, T.; Michalek, I.M.; Miller, T.R.; Mirrakhimov, E.M.; Mirzaei, H.; Moazen, B.; Moghadaszadeh, M.; Mohammad, Y.; Mohammad, D.K.; Mohammed, S.; Mohammed, M.A.; Mokhayeri, Y.; Molokhia, M.; Montasir, A.A.; Moradi, G.; Moradzadeh, R.; Moraga, P.; Morawska, L.; Moreno Velásquez, I.; Morze, J.; Mubarik, S.; Muruet, W.; Musa, K.I.; Nagarajan, A.J.; Nalini, M.; Nangia, V.; Naqvi, A.A.; Narasimha Swamy, S.; Nascimento, B.R.; Nayak, V.C.; Nazari, J.; Nazarzadeh, M.; Negoi, R.I.; Neupane Kandel, S.; Nguyen, H.L.T.; Nixon, M.R.; Norrving, B.; Noubiap, J.J.; Nouthe, B.E.; Nowak, C.; Odukoya, O.O.; Ogbo, F.A.; Olagunju, A.T.; Orru, H.; Ortiz, A.; Ostroff, S.M.; Padubidri, J.R.; Palladino, R.; Pana, A.; Panda-Jonas, S.; Parekh, U.; Park, E-C.; Parvizi, M.; Pashazadeh Kan, F.; Patel, U.K.; Pathak, M.; Paudel, R.; Pepito, V.C.F.; Perianayagam, A.; Perico, N.; Pham, H.Q.; Pilgrim, T.; Piradov, M.A.; Pishgar, F.; Podder, V.; Polibin, R.V.; Pourshams, A.; Pribadi, D.R.A.; Rabiee, N.; Rabiee, M.; Radfar, A.; Rafiei, A.; Rahim, F.; Rahimi-Movaghar, V.; Ur Rahman, M.H.; Rahman, M.A.; Rahmani, A.M.; Rakovac, I.; Ram, P.; Ramalingam, S.; Rana, J.; Ranasinghe, P.; Rao, S.J.; Rathi, P.; Rawal, L.; Rawasia, W.F.; Rawassizadeh, R.; Remuzzi, G.; Renzaho, A.M.N.; Rezapour, A.; Riahi, S.M.; Roberts-Thomson, R.L.; Roever, L.; Rohloff, P.; Romoli, M.; Roshandel, G.; Rwegerera, G.M.; Saadatagah, S.; Saber-Ayad, M.M.; Sabour, S.; Sacco, S.; Sadeghi, M.; Saeedi Moghaddam, S.; Safari, S.; Sahebkar, A.; Salehi, S.; Salimzadeh, H.; Samaei, M.; Samy, A.M.; Santos, I.S.; Santric-Milicevic, M.M.; Sarrafzadegan, N.; Sarveazad, A.; Sathish, T.; Sawhney, M.; Saylan, M.; Schmidt, M.I.; Schutte, A.E.; Senthilkumaran, S.; Sepanlou, S.G.; Sha, F.; Shahabi, S.; Shahid, I.; Shaikh, M.A.; Shamali, M.; Shamsizadeh, M.; Shawon, M.S.R.; Sheikh, A.; Shigematsu, M.; Shin, M-J.; Shin, J.I.; Shiri, R.; Shiue, I.; Shuval, K.; Siabani, S.; Siddiqi, T.J.; Silva, D.A.S.; Singh, J.A.; Mtech, A.S.; Skryabin, V.Y.; Skryabina, A.A.; Soheili, A.; Spurlock, E.E.; Stockfelt, L.; Stortecky, S.; Stranges, S.; Suliankatchi Abdulkader, R.; Tadbiri, H.; Tadesse, E.G.; Tadesse, D.B.; Tajdini, M.; Tariqujjaman, M.; Teklehaimanot, B.F.; Temsah, M-H.; Tesema, A.K.; Thakur, B.; Thankappan, K.R.; Thapar, R.; Thrift, A.G.; Timalsina, B.; Tonelli, M.; Touvier, M.; Tovani-Palone, M.R.; Tripathi, A.; Tripathy, J.P.; Truelsen, T.C.; Tsegay, G.M.; Tsegaye, G.W.; Tsilimparis, N.; Tusa, B.S.; Tyrovolas, S.; Umapathi, K.K.; Unim, B.; Unnikrishnan, B.; Usman, M.S.; Vaduganathan, M.; Valdez, P.R.; Vasankari, T.J.; Velazquez, D.Z.; Venketasubramanian, N.; Vu, G.T.; Vujcic, I.S.; Waheed, Y.; Wang, Y.; Wang, F.; Wei, J.; Weintraub, R.G.; Weldemariam, A.H.; Westerman, R.; Winkler, A.S.; Wiysonge, C.S.; Wolfe, C.D.A.; Wubishet, B.L.; Xu, G.; Yadollahpour, A.; Yamagishi, K.; Yan, L.L.; Yandrapalli, S.; Yano, Y.; Yatsuya, H.; Yeheyis, T.Y.; Yeshaw, Y.; Yilgwan, C.S.; Yonemoto, N.; Yu, C.; Yusefzadeh, H.; Zachariah, G.; Zaman, S.B.; Zaman, M.S.; Zamanian, M.; Zand, R.; Zandifar, A.; Zarghi, A.; Zastrozhin, M.S.; Zastrozhina, A.; Zhang, Z-J.; Zhang, Y.; Zhang, W.; Zhong, C.; Zou, Z.; Zuniga, Y.M.H.; Murray, C.J.L.; Fuster, V. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. J. Am. Coll. Cardiol., 2020, 76(25), 2982-3021.
[http://dx.doi.org/10.1016/j.jacc.2020.11.010] [PMID: 33309175]

Joseph, P.; Leong, D.; McKee, M.; Anand, S.S.; Schwalm, J.D.; Teo, K.; Mente, A.; Yusuf, S. Reducing the global burden of cardiovascular disease, part 1. Circ. Res., 2017, 121(6), 677-694.
[http://dx.doi.org/10.1161/CIRCRESAHA.117.308903] [PMID: 28860318]

Kundu, J.; Kundu, S. Cardiovascular disease (CVD) and its associated risk factors among older adults in India: Evidence from LASI Wave 1. Clin. Epidemiol. Glob. Health, 2022, 13100937
[http://dx.doi.org/10.1016/j.cegh.2021.100937]

Liu, M.B. Cardiovascular diseases. Chin. Med. J. (Engl.), 2014, 127, 6-7.
[PMID: 23557570]

Martín-Timón, I.; Sevillano-Collantes, C.; Segura-Galindo, A.; Del Cañizo-Gómez, F.J. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J. Diabetes, 2014, 5(4), 444-470.
[PMID: 25126392]

Ormazabal, V.; Nair, S.; Elfeky, O.; Aguayo, C.; Salomon, C.; Zuñiga, F.A. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc. Diabetol., 2018, 17(1), 122.
[http://dx.doi.org/10.1186/s12933-018-0762-4] [PMID: 30170598]

Einarson, T.R.; Acs, A.; Ludwig, C.; Panton, U.H. Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007-2017. Cardiovasc. Diabetol., 2018, 17(1), 83.
[http://dx.doi.org/10.1186/s12933-018-0728-6] [PMID: 29884191]

Schwarz, P.E.H.; Timpel, P.; Harst, L.; Greaves, C.J.; Ali, M.K.; Lambert, J.; Weber, M.B.; Almedawar, M.M.; Morawietz, H. Blood sugar regulation for cardiovascular health promotion and disease prevention: JACC health promotion series. J. Am. Coll. Cardiol., 2018, 72(15), 1829-1844.
[PMID: 30286928]

Qaseem, A.; Wilt, T.J.; Kansagara, D.; Horwitch, C.; Barry, M.J.; Forciea, M.A.; Fitterman, N.; Balzer, K.; Boyd, C.; Humphrey, L.L.; Iorio, A.; Lin, J.; Maroto, M.; McLean, R.; Mustafa, R.; Tufte, J. Haemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the american college of physicians. Ann. Intern. Med., 2018, 168(8), 569-576.
[PMID: 29507945]

Chaudhury, A.; Duvoor, C.; Reddy Dendi, V.S.; Kraleti, S.; Chada, A.; Ravilla, R.; Marco, A.; Shekhawat, N.S.; Montales, M.T.; Kuriakose, K.; Sasapu, A.; Beebe, A.; Patil, N.; Musham, C.K.; Lohani, G.P.; Mirza, W. Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Front. Endocrinol., 2017, 8, 6.
[http://dx.doi.org/10.3389/fendo.2017.00006] [PMID: 28167928]

Peene, B.; Benhalima, K. Sodium glucose transporter protein 2 inhibitors: Focusing on the kidney to treat type 2 diabetes. Ther. Adv. Endocrinol. Metab., 2014, 5(5), 124-136.
[http://dx.doi.org/10.1177/2042018814553965] [PMID: 25419452]

Heerspink, H.J.L.; Perkins, B.A.; Fitchett, D.H.; Husain, M.; Cherney, D.Z.I. Sodium-glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus. Circulation, 2016, 134(10), 752-772.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.021887] [PMID: 27470878]

Lim, S.; Bae, J.H.; Kwon, H.S.; Nauck, M.A. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat. Rev. Endocrinol., 2021, 17(1), 11-30.
[http://dx.doi.org/10.1038/s41574-020-00435-4] [PMID: 33188364]

Kalra, S. Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors: A review of their basic and clinical pharmacology. Diabetes Ther., 2014, 5(2), 355-366.
[http://dx.doi.org/10.1007/s13300-014-0089-4] [PMID: 25424969]

Tentolouris, A.; Vlachakis, P.; Tzeravini, E.; Eleftheriadou, I.; Tentolouris, N. SGLT2 inhibitors: A review of their antidiabetic and cardioprotective effects. Int. J. Environ. Res. Public Health, 2019, 16(16), 2965.
[http://dx.doi.org/10.3390/ijerph16162965] [PMID: 31426529]

Chu, C.; Lu, Y.P.; Yin, L.; Hocher, B. The SGLT2 inhibitor empagliflozin might be a new approach to prevent acute kidney injury. Kidney Blood Press. Res., 2019, 44(2), 149-157.
[http://dx.doi.org/10.1159/000498963] [PMID: 30939483]

Xu, D.; Chandler, O.; Wee, C.; Ho, C.; Affandi, J.S.; Yang, D.; Liao, X.; Chen, W.; Li, Y.; Reid, C.; Xiao, H. Sodium-glucose cotransporter-2 inhibitor (SGLT2i) as a primary preventative agent in the healthy individual: A need of a future randomised clinical trial? Front. Med., 2021, 8712671
[http://dx.doi.org/10.3389/fmed.2021.712671] [PMID: 34497814]

Lupsa, B.C.; Inzucchi, S.E. Use of SGLT2 inhibitors in type 2 diabetes: Weighing the risks and benefits. Diabetologia, 2018, 61(10), 2118-2125.
[http://dx.doi.org/10.1007/s00125-018-4663-6] [PMID: 30132031]

Cai, R.; Xu, Y.; Su, Q. Dapagliflozin in patients with chronic heart failure: A systematic review and meta-analysis. Cardiol. Res. Pract., 2021, 2021, 1-12.
[http://dx.doi.org/10.1155/2021/6657380] [PMID: 33859839]

Martinez, F.A.; Serenelli, M.; Nicolau, J.C.; Petrie, M.C.; Chiang, C.E.; Tereshchenko, S.; Solomon, S.D.; Inzucchi, S.E.; Køber, L.; Kosiborod, M.N.; Ponikowski, P.; Sabatine, M.S.; DeMets, D.L.; Dutkiewicz-Piasecka, M.; Bengtsson, O.; Sjöstrand, M.; Langkilde, A.M.; Jhund, P.S.; McMurray, J.J.V. Efficacy and safety of dapagliflozin in heart failure with reduced ejection fraction according to age. Circulation, 2020, 141(2), 100-111.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044133] [PMID: 31736328]

Vasquez-Rios, G.; Nadkarni, G.N. SGLT2 inhibitors: Emerging roles in the protection against cardiovascular and kidney disease among diabetic patients. Int. J. Nephrol. Renovasc. Dis., 2020, 13, 281-296.
[http://dx.doi.org/10.2147/IJNRD.S268811] [PMID: 33149657]

Giorgino, F.; Vora, J.; Fenici, P.; Solini, A. Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk. Cardiovasc. Diabetol., 2020, 19(1), 196.
[http://dx.doi.org/10.1186/s12933-020-01163-9] [PMID: 33222693]

Kuriyama, S. A potential mechanism of cardio-renal protection with sodium-glucose cotransporter 2 inhibitors: Amelioration of renal congestion. Kidney Blood Press. Res., 2019, 44(4), 449-456.
[http://dx.doi.org/10.1159/000501081] [PMID: 31291624]

Uthman, L.; Baartscheer, A.; Schumacher, C.A.; Fiolet, J.W.T.; Kuschma, M.C.; Hollmann, M.W.; Coronel, R.; Weber, N.C.; Zuurbier, C.J. Direct cardiac actions of sodium-glucose cotransporter 2 inhibitors target pathogenic mechanisms underlying heart failure in diabetic patients. Front. Physiol., 2018, 9, 1575.
[http://dx.doi.org/10.3389/fphys.2018.01575] [PMID: 30519189]

Joshi, S.S.; Singh, T.; Newby, D.E.; Singh, J. Sodium-glucose co-transporter 2 inhibitor therapy: Mechanisms of action in heart failure. Heart, 2021, 107(13), 1032-1038.
[http://dx.doi.org/10.1136/heartjnl-2020-318060]

Verma, S. Potential mechanisms of sodium-glucose co-transporter 2 inhibitor-related cardiovascular benefits. Am. J. Cardiol., 2019, 124(10)(Suppl. 1), S36-S44.
[http://dx.doi.org/10.1016/j.amjcard.2019.10.028] [PMID: 31741439]

Neuen, B.L.; Young, T.; Heerspink, H.J.L.; Neal, B.; Perkovic, V.; Billot, L.; Mahaffey, K.W.; Charytan, D.M.; Wheeler, D.C.; Arnott, C.; Bompoint, S.; Levin, A.; Jardine, M.J. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: A systematic review and meta-analysis. Lancet Diabetes Endocrinol., 2019, 7(11), 845-854.
[http://dx.doi.org/10.1016/S2213-8587(19)30256-6] [PMID: 31495651]

Davidson, J.A. SGLT2 inhibitors in patients with type 2 diabetes and renal disease: Overview of current evidence. Postgrad. Med., 2019, 131(4), 251-260.
[http://dx.doi.org/10.1080/00325481.2019.1601404] [PMID: 30929540]

Arnott, C.; Li, Q.; Kang, A.; Neuen, B.L.; Bompoint, S.; Lam, C.S.P.; Rodgers, A.; Mahaffey, K.W.; Cannon, C.P.; Perkovic, V.; Jardine, M.J.; Neal, B. Sodium‐glucose cotransporter 2 inhibition for the prevention of cardiovascular events in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis. J. Am. Heart Assoc., 2020, 9(3)e014908
[http://dx.doi.org/10.1161/JAHA.119.014908] [PMID: 31992158]

Milder, T.Y.; Stocker, S.L.; Day, R.O.; Greenfield, J.R. Potential safety issues with use of sodium-glucose cotransporter 2 inhibitors, particularly in people with type 2 diabetes and chronic kidney disease. Drug Saf., 2020, 43(12), 1211-1221.
[http://dx.doi.org/10.1007/s40264-020-01010-6] [PMID: 33095409]

Morris, D. SGLT2 inhibitors – Moving on with the evidence. J. Diabetes Nurs., 2019, 23(4)

Gyimesi, G.; Pujol-Giménez, J.; Kanai, Y.; Hediger, M.A. Sodium-coupled glucose transport, the SLC5 family, and therapeutically relevant inhibitors: From molecular discovery to clinical application. Pflugers Arch., 2020, 472(9), 1177-1206.
[http://dx.doi.org/10.1007/s00424-020-02433-x] [PMID: 32767111]

Sano, R.; Shinozaki, Y.; Ohta, T. Sodium–glucose cotransporters: Functional properties and pharmaceutical potential. J. Diabetes Investig., 2020, 11(4), 770-782.
[http://dx.doi.org/10.1111/jdi.13255] [PMID: 32196987]

Santer, R.; Calado, J. Familial renal glucosuria and SGLT2: From a mendelian trait to a therapeutic target. Clin. J. Am. Soc. Nephrol., 2010, 5(1), 133-141.
[http://dx.doi.org/10.2215/CJN.04010609] [PMID: 19965550]

Pérez López, G.; González Albarrán, O.; Cano Megías, M. Sodium-glucose cotransporter type 2 inhibitors (SGLT2): From familial renal glucosuria to the treatment of type 2 diabetes mellitus. Nefrologia, 2010, 30(6), 618-625.
[PMID: 21113210]

Sahoo, S.; Aurich, M.K.; Jonsson, J.J.; Thiele, I. Membrane transporters in a human genome-scale metabolic knowledgebase and their implications for disease. Front. Physiol., 2014, 5, 91.
[http://dx.doi.org/10.3389/fphys.2014.00091] [PMID: 24653705]

Ni, L.; Yuan, C.; Chen, G.; Zhang, C.; Wu, X. SGLT2i: Beyond the glucose-lowering effect. Cardiovasc. Diabetol., 2020, 19(1), 98.
[http://dx.doi.org/10.1186/s12933-020-01071-y] [PMID: 32590982]

Abdul-Ghani, M.A.; Norton, L.; DeFronzo, R.A. Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus. Am. J. Physiol. Renal Physiol., 2015, 309(11), F889-F900.
[http://dx.doi.org/10.1152/ajprenal.00267.2015] [PMID: 26354881]

Ghezzi, C.; Loo, D.D.F.; Wright, E.M. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. Diabetologia, 2018, 61(10), 2087-2097.
[http://dx.doi.org/10.1007/s00125-018-4656-5] [PMID: 30132032]

Ferrannini, E. Sodium-glucose co-transporters and their inhibition: Clinical physiology. Cell Metab., 2017, 26(1), 27-38.
[http://dx.doi.org/10.1016/j.cmet.2017.04.011] [PMID: 28506519]

Singh, P.; Jain, P.; Shukla, S.; Pandey, R. Phytotherapeutic review on diabetes. Spat DD – Peer. Rev. J. Complement. Med. Drug Discov., 2016, 6(2), 1.

Harada, N.; Inagaki, N. Role of sodium-glucose transporters in glucose uptake of the intestine and kidney. J. Diabetes Investig., 2012, 3(4), 352-353.
[http://dx.doi.org/10.1111/j.2040-1124.2012.00227.x] [PMID: 24843589]

Chen, J.; Williams, S.; Ho, S.; Loraine, H.; Hagan, D.; Whaley, J.M.; Feder, J.N. Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther., 2010, 1(2), 57-92.
[http://dx.doi.org/10.1007/s13300-010-0006-4] [PMID: 22127746]

Szablewski, L. Distribution of glucose transporters in renal diseases. J. Biomed. Sci., 2017, 24(1), 64.
[http://dx.doi.org/10.1186/s12929-017-0371-7] [PMID: 28854935]

Augustin, R. Mammalian sugar transporters. In: Glucose Homeostasis; Szablewski, E.M.E.L., Ed.; IntechOpen: Rijeka, 2014.
[http://dx.doi.org/10.5772/58325]

Lam, C.S.P.; Chandramouli, C.; Ahooja, V.; Verma, S. SGLT‐2 inhibitors in heart failure: Current management, unmet needs, and therapeutic prospects. J. Am. Heart Assoc., 2019, 8(20)e013389
[http://dx.doi.org/10.1161/JAHA.119.013389] [PMID: 31607208]

Griffin, M.; Rao, V.S.; Ivey-Miranda, J.; Fleming, J.; Mahoney, D.; Maulion, C.; Suda, N.; Siwakoti, K.; Ahmad, T.; Jacoby, D.; Riello, R.; Bellumkonda, L.; Cox, Z.; Collins, S.; Jeon, S.; Turner, J.M.; Wilson, F.P.; Butler, J.; Inzucchi, S.E.; Testani, J.M. Empagliflozin in heart failure. Circulation, 2020, 142(11), 1028-1039.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.120.045691] [PMID: 32410463]

Packer, M.; Anker, S.D.; Butler, J.; Filippatos, G.; Pocock, S.J.; Carson, P.; Januzzi, J.; Verma, S.; Tsutsui, H.; Brueckmann, M.; Jamal, W.; Kimura, K.; Schnee, J.; Zeller, C.; Cotton, D.; Bocchi, E.; Böhm, M.; Choi, D.J.; Chopra, V.; Chuquiure, E.; Giannetti, N.; Janssens, S.; Zhang, J.; Gonzalez Juanatey, J.R.; Kaul, S.; Brunner-La Rocca, H.P.; Merkely, B.; Nicholls, S.J.; Perrone, S.; Pina, I.; Ponikowski, P.; Sattar, N.; Senni, M.; Seronde, M.F.; Spinar, J.; Squire, I.; Taddei, S.; Wanner, C.; Zannad, F. Cardiovascular and renal outcomes with empagliflozin in heart failure. N. Engl. J. Med., 2020, 383(15), 1413-1424.
[http://dx.doi.org/10.1056/NEJMoa2022190] [PMID: 32865377]

Shao, Q.; Meng, L.; Lee, S.; Tse, G.; Gong, M.; Zhang, Z.; Zhao, J.; Zhao, Y.; Li, G.; Liu, T. Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats. Cardiovasc. Diabetol., 2019, 18(1), 165.
[http://dx.doi.org/10.1186/s12933-019-0964-4] [PMID: 31779619]

Das, U.S.; Paul, A.; Banerjee, S. SGLT2 inhibitors in heart failure with reduced ejection fraction. Egypt. Heart J., 2021, 73(1), 93.
[http://dx.doi.org/10.1186/s43044-021-00218-w] [PMID: 34693498]

Zinman, B.; Wanner, C.; Lachin, J.M.; Fitchett, D.; Bluhmki, E.; Hantel, S.; Mattheus, M.; Devins, T.; Johansen, O.E.; Woerle, H.J.; Broedl, U.C.; Inzucchi, S.E. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med., 2015, 373(22), 2117-2128.
[http://dx.doi.org/10.1056/NEJMoa1504720] [PMID: 26378978]

Budoff, M.J.; Wilding, J.P.H. Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus. Int. J. Clin. Pract., 2017, 71(5)e12948
[http://dx.doi.org/10.1111/ijcp.12948] [PMID: 28508457]

Schernthaner, G.; Shehadeh, N.; Ametov, A.S.; Bazarova, A.V.; Ebrahimi, F.; Fasching, P.; Janež, A.; Kempler, P. Konrāde, I.; Lalić N.M.; Mankovsky, B.; Martinka, E.; Rahelić D.; Serafinceanu, C.; Škrha, J.; Tankova, T.; Visockienė Ž. Worldwide inertia to the use of cardiorenal protective glucose-lowering drugs (SGLT2i and GLP-1 RA) in high-risk patients with type 2 diabetes. Cardiovasc. Diabetol., 2020, 19(1), 185.
[PMID: 33097060]

Rangaswami, J.; Bhalla, V.; de Boer, I.H.; Staruschenko, A.; Sharp, J.A.; Singh, R.R.; Lo, K.B.; Tuttle, K.; Vaduganathan, M.; Ventura, H.; McCullough, P.A. Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease: A scientific statement from the American heart association. Circulation, 2020, 142(17), e265-e286.
[http://dx.doi.org/10.1161/CIR.0000000000000920] [PMID: 32981345]

Saleem, F. Dapagliflozin: Cardiovascular safety and benefits in type 2 diabetes mellitus. Cureus, 2017, 9(10)e1751
[http://dx.doi.org/10.7759/cureus.1751] [PMID: 29226041]

Wiviott, S.D.; Raz, I.; Bonaca, M.P.; Mosenzon, O.; Kato, E.T.; Cahn, A.; Silverman, M.G.; Zelniker, T.A.; Kuder, J.F.; Murphy, S.A.; Bhatt, D.L.; Leiter, L.A.; McGuire, D.K.; Wilding, J.P.H.; Ruff, C.T.; Gause-Nilsson, I.A.M.; Fredriksson, M.; Johansson, P.A.; Langkilde, A.M.; Sabatine, M.S. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med., 2019, 380(4), 347-357.
[http://dx.doi.org/10.1056/NEJMoa1812389] [PMID: 30415602]

Zhai, M.; Du, X.; Liu, C.; Xu, H. The effects of dapagliflozin in patients with heart failure complicated with type 2 diabetes: a meta-analysis of placebo-controlled randomized trials. Front. Clin. Diabetes Healthc., 2021, 2703937

Neeland, I.J.; Salahuddin, U.; McGuire, D.K. A safety evaluation of empagliflozin for the treatment of type 2 diabetes. Expert Opin. Drug Saf., 2016, 15(3), 393-402.
[http://dx.doi.org/10.1517/14740338.2016.1135900] [PMID: 26695551]

Jain, A.; Jain, P.; Parihar, D.K. Comparative study of in-vitro antidiabetic and antibacterial activity of non-conventional curcuma species. J. Biologic. Active Prod. Nature, 2019, 9(6), 457-464.
[http://dx.doi.org/10.1080/22311866.2019.1710253]

Ferdinand, K.C.; Izzo, J.L.; Lee, J.; Meng, L.; George, J.; Salsali, A.; Seman, L. Antihyperglycemic and blood pressure effects of empagliflozin in black patients with type 2 diabetes mellitus and hypertension. Circulation, 2019, 139(18), 2098-2109.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.118.036568] [PMID: 30786754]

Marrs, J.C.; Anderson, S.L. Ertugliflozin in the treatment of type 2 diabetes mellitus. Drugs Context, 2020, 9, 1-10.
[http://dx.doi.org/10.7573/dic.2020-7-4] [PMID: 33293984]

Zhang, C.; Zhang, X.; Wang, P.; Zhu, Q.; Mei, Y.; Zhang, Z.; Xu, H. Effect of SGLT2 inhibitors on risk of stroke in diabetes: A meta-analysis. Cerebrovasc. Dis., 2022, 51(5), 585-593.
[http://dx.doi.org/10.1159/000521782] [PMID: 35100586]

Cowie, M.R.; Fisher, M. SGLT2 inhibitors: Mechanisms of cardiovascular benefit beyond glycaemic control. Nat. Rev. Cardiol., 2020, 17(12), 761-772.
[http://dx.doi.org/10.1038/s41569-020-0406-8] [PMID: 32665641]

Lopaschuk, G.D.; Verma, S. Mechanisms of cardiovascular benefits of sodium-glucose co-transporter 2 (SGLT2) inhibitors: A state-of-the-art review. JACC Basic Transl. Sci., 2020, 5(6), 632-644.
[http://dx.doi.org/10.1016/j.jacbts.2020.02.004] [PMID: 32613148]

Wilkinson, I.B.; McEniery, C.M. Arterial stiffness, endothelial function and novel pharmacological approaches. Clin. Exp. Pharmacol. Physiol., 2004, 31(11), 795-799.
[http://dx.doi.org/10.1111/j.1440-1681.2004.04074.x] [PMID: 15566396]

Cherney, D.Z.I.; Perkins, B.A.; Soleymanlou, N.; Har, R.; Fagan, N.; Johansen, O.; Woerle, H.J.; von Eynatten, M.; Broedl, U.C. The effect of empagliflozin on arterial stiffness and heart rate variability in subjects with uncomplicated type 1 diabetes mellitus. Cardiovasc. Diabetol., 2014, 13(1), 28.
[http://dx.doi.org/10.1186/1475-2840-13-28] [PMID: 24475922]

Lee, T.M.; Chang, N.C.; Lin, S.Z. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts. Free Radic. Biol. Med., 2017, 104, 298-310.
[http://dx.doi.org/10.1016/j.freeradbiomed.2017.01.035] [PMID: 28132924]

Thrailkill, K.M.; Bunn, R.C.; Uppuganti, S.; Ray, P.; Garrett, K.; Popescu, I.; Pennings, J.S.; Fowlkes, J.L.; Nyman, J.S. Genetic ablation of SGLT2 function in mice impairs tissue mineral density but does not affect fracture resistance of bone. Bone, 2020, 133115254
[http://dx.doi.org/10.1016/j.bone.2020.115254] [PMID: 31991250]

McMurray, J.J.V.; Solomon, S.D.; Inzucchi, S.E.; Køber, L.; Kosiborod, M.N.; Martinez, F.A.; Ponikowski, P.; Sabatine, M.S.; Anand, I.S. Bělohlávek, J.; Böhm, M.; Chiang, C.E.; Chopra, V.K.; de Boer, R.A.; Desai, A.S.; Diez, M.; Drozdz, J.; Dukát, A.; Ge, J.; Howlett, J.G.; Katova, T.; Kitakaze, M.; Ljungman, C.E.A.; Merkely, B.; Nicolau, J.C.; O’Meara, E.; Petrie, M.C.; Vinh, P.N.; Schou, M.; Tereshchenko, S.; Verma, S.; Held, C.; DeMets, D.L.; Docherty, K.F.; Jhund, P.S.; Bengtsson, O.; Sjöstrand, M.; Langkilde, A.M. Dapagliflozin in patients with heart failure and reduced ejection fraction. N. Engl. J. Med., 2019, 381(21), 1995-2008.
[http://dx.doi.org/10.1056/NEJMoa1911303] [PMID: 31535829]

Mendoza, V.L.; Tumanan-Mendoza, B.A.; Punzalan, F.E.R. Cost‐utility analysis of add‐on dapagliflozin in heart failure with reduced ejection fraction in the Philippines. ESC Heart Fail., 2021, 8(6), 5132-5141.
[http://dx.doi.org/10.1002/ehf2.13583] [PMID: 34494399]

Hayashi, T.; Fukui, T.; Nakanishi, N.; Yamamoto, S.; Tomoyasu, M.; Osamura, A.; Ohara, M.; Yamamoto, T.; Ito, Y.; Hirano, T. Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: Comparison with sitagliptin. Cardiovasc. Diabetol., 2017, 16(1), 8.
[http://dx.doi.org/10.1186/s12933-016-0491-5] [PMID: 28086872]

Pittampalli, S.; Upadyayula, S.; Mekala, H.M.; Lippmann, S. Risks vs benefits for SGLT2 inhibitor medications. Fed. Pract., 2018, 35(7), 45-48.
[PMID: 30766374]

Kalra, S. Sodium-Glucose Cotransporter 2 (SGLT2) inhibitors and cardiovascular disease: A systematic review. Cardiol. Ther., 2016, 5(2), 161-168.
[http://dx.doi.org/10.1007/s40119-016-0069-z] [PMID: 27539303]

Vasilakou, D.; Karagiannis, T.; Athanasiadou, E.; Mainou, M.; Liakos, A.; Bekiari, E.; Sarigianni, M.; Matthews, D.R.; Tsapas, A. Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: A systematic review and meta-analysis. Ann. Intern. Med., 2013, 159(4), 262-274.
[http://dx.doi.org/10.7326/0003-4819-159-4-201308200-00007] [PMID: 24026259]

Deedwania, P. SGLT2 inhibitors: The dawn of a new era in cardio-metabolic therapeutics. Am. J. Cardiovasc. Drugs, 2022, 22(1), 1-4.
[http://dx.doi.org/10.1007/s40256-021-00495-5] [PMID: 34458960]

Packer, M. SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: A paradigm shift in understanding their mechanism of action. Diabetes Care, 2020, 43(3), 508-511.
[http://dx.doi.org/10.2337/dci19-0074] [PMID: 32079684]

Scheen, A.J. Effect of SGLT2 inhibitors on the sympathetic nervous system and blood pressure. Curr. Cardiol. Rep., 2019, 21(8), 70.
[http://dx.doi.org/10.1007/s11886-019-1165-1] [PMID: 31227915]

Grassi, G.; Mark, A.; Esler, M. The sympathetic nervous system alterations in human hypertension. Circ. Res., 2015, 116(6), 976-990.
[http://dx.doi.org/10.1161/CIRCRESAHA.116.303604] [PMID: 25767284]

Parati, G.; Esler, M. The human sympathetic nervous system: Its relevance in hypertension and heart failure. Eur. Heart J., 2012, 33(9), 1058-1066.
[PMID: 22507981]

Toschi-Dias, E.; Rondon, M.U.P.B.; Cogliati, C.; Paolocci, N.; Tobaldini, E.; Montano, N. Contribution of autonomic reflexes to the hyperadrenergic state in heart failure. Front. Neurosci., 2017, 11, 162.
[http://dx.doi.org/10.3389/fnins.2017.00162] [PMID: 28424575]

van Bilsen, M.; Patel, H.C.; Bauersachs, J.; Böhm, M.; Borggrefe, M.; Brutsaert, D.; Coats, A.J.S.; de Boer, R.A.; de Keulenaer, G.W.; Filippatos, G.S.; Floras, J.; Grassi, G.; Jankowska, E.A.; Kornet, L.; Lunde, I.G.; Maack, C.; Mahfoud, F.; Pollesello, P.; Ponikowski, P.; Ruschitzka, F.; Sabbah, H.N.; Schultz, H.D.; Seferovic, P.; Slart, R.H.J.A.; Taggart, P.; Tocchetti, C.G.; Van Laake, L.W.; Zannad, F.; Heymans, S.; Lyon, A.R. The autonomic nervous system as a therapeutic target in heart failure: A scientific position statement from the translational research committee of the heart failure association of the european society of cardiology. Eur. J. Heart Fail., 2017, 19(11), 1361-1378.
[http://dx.doi.org/10.1002/ejhf.921] [PMID: 28949064]

Briasoulis, A.; Al Dhaybi, O.; Bakris, G.L. SGLT2 inhibitors and mechanisms of hypertension. Curr. Cardiol. Rep., 2018, 20(1), 1.
[http://dx.doi.org/10.1007/s11886-018-0943-5] [PMID: 29349558]

Donkor, E.S. Stroke in the 21st century: A snapshot of the burden, epidemiology, and quality of life. Stroke Res. Treat., 2018, 2018, 1-10.
[http://dx.doi.org/10.1155/2018/3238165] [PMID: 30598741]

Shi, L.; Rocha, M.; Leak, R.K.; Zhao, J.; Bhatia, T.N.; Mu, H.; Wei, Z.; Yu, F.; Weiner, S.L.; Ma, F.; Jovin, T.G.; Chen, J. A new era for stroke therapy: Integrating neurovascular protection with optimal reperfusion. J. Cereb. Blood Flow Metab., 2018, 38(12), 2073-2091.
[http://dx.doi.org/10.1177/0271678X18798162] [PMID: 30191760]

Al Hamed, F.A.; Elewa, H. Potential therapeutic effects of sodium glucose-linked cotransporter 2 inhibitors in stroke. Clin. Ther., 2020, 42(11), e242-e249.
[http://dx.doi.org/10.1016/j.clinthera.2020.09.008] [PMID: 33008610]

Tsai, W.H.; Chuang, S.M.; Liu, S.C.; Lee, C.C.; Chien, M.N.; Leung, C.H.; Liu, S.J.; Shih, H.M. Effects of SGLT2 inhibitors on stroke and its subtypes in patients with type 2 diabetes: A systematic review and meta-analysis. Sci. Rep., 2021, 11(1), 15364.
[http://dx.doi.org/10.1038/s41598-021-94945-4] [PMID: 34321571]

Zhou, Z.; Jardine, M.J.; Li, Q.; Neuen, B.L.; Cannon, C.P.; de Zeeuw, D.; Edwards, R.; Levin, A.; Mahaffey, K.W.; Perkovic, V.; Neal, B.; Lindley, R.I.; Ahuad, R.A.; Aizenberg, D.; Albisu, J.P.; Alvarisqueta, A.; Bartolacci, I.; Berli, M.A.; Bordonava, A.; Calella, P.; Cantero, M.C.; Cartasegna, L.R.; Cercos, E.; Coloma, G.C.; Colombo, H.; Commendatore, V.; Cuadrado, J.; Cuneo, C.A.; Cusumano, A.M.; Douthat, W.G.; Dran, R.D.; Farias, E.; Fernandez, M.F.; Finkelstein, H.; Fragale, G.; Fretes, J.O.; Garcia, N.H.; Gastaldi, A.; Gelersztein, E.; Glenny, J.A.; Gonzalez, J.P.; del Carmen Gonzalez Colaso, P.; Goycoa, C.; Greloni, G.C.; Guinsburg, A.; Hermida, S.; Juncos, L.I.; Klyver, M.I.; Kraft, F.; Krynski, F.; Lanchiotti, P.V.; Leon de la Fuente, R.A.; Marchetta, N.; Mele, P.; Nicolai, S.; Novoa, P.A.; Orio, S.I.; Otreras, F.; Oviedo, A.; Raffaele, P.; Resk, J.H.; Rista, L.; Rodriguez, N.; Sala, J.; Santos, J.C.; Schiavi, L.B.; Sessa, H.; Smith Casabella, T.; Ulla, M.R.; Valdez, M.; Vallejos, A.; Villarino, A.; Visco, V.E.; Wassermann, A.; Zaidman, C.J.; Cheung, N.W.; Droste, C.; Fraser, I.; Johnson, D.; Mah, P.M.; Nicholls, K.; Packham, D.; Proietto, J.; Roberts, A.; Roger, S.; Tsang, V.; Abrão, R. R.; Alves da Costa, F.A.; Amodeo, C.; Andreotti T., L.A.; Bregman, R.; Camelo Sanches, F.C.; Canani, L.H.; Chacra, A.R.; Cunha Borges, J.L.; Cunha Vêncio, S.A.; da Silva Franco, R.J.; d’Avila, D.; de Souza Portes, E.; de Souza, P.; Deboni, L.M.; Fraige Filho, F.; Geloneze Neto, B.; Gomes, M.; Keiko, K., S.; Keitel, E.; Kerr Saraiva, J.F.; Kurtz, L., H.R.; Loss de Carvalho Contieri, F.; Milagres, R.; Montenegro J., R.; Moreira de Brito, C.; Nasser, H. M.; Nazario, S., Â.R.; Noronha, I.; Panarotto, D.; Pecoits, F., R.; Pereira, M.A.; Saporito, W.; Scafuto S., A.; Schuch, T.; Simões de Almeida, R.; Slompo R, C.; Soares Felício, J.; Thomé, F.; Tibes Hachmann, J.C.; Yamada, S.; Yoiti H., C.; Zanata P., T.B.; Zanella, M.T.; Andreeva, V.; Angelova, A.; Dimitrov, S.; Genadieva, V.; Genova-Hristova, G.; Hristozov, K.; Kamenov, Z.; Koundurdjiev, A.; Lozanov, L.; Margaritov, V.; Nonchev, B.; Rangelov, R.; Shinkov, A.; Temelkova, M.; Velichkova, E.; Yakov, A.; Aggarwal, N.; Aronson, R.; Bajaj, H.; Cherney, D.; Chouinard, G.; Conway, J.; Cournoyer, S.; DaRoza, G.; De Serres, S.; Dubé, F.; Goldenberg, R.; Gupta, A.; Gupta, M.; Henein, S.; Khandwala, H.; Leiter, L.; Madore, F.; McMahon, A.; Muirhead, N.; Pichette, V.; Rabasa-Lhoret, R.; Steele, A.; Tangri, N.; Torshizi, A.; Woo, V.; Zalunardo, N.; Fernández, M., M.A.; Godoy J., J.G.; Medina, F., M.; Saavedra Gajardo, V.; Vejar, M.; Chen, N.; Chen, Q.; Gan, S.; Kong, Y.; Li, D.; Li, W.; Li, X.; Lin, H.; Liu, J.; Lu, W.; Mao, H.; Ren, Y.; Song, W.; Sun, J.; Sun, L.; Tu, P.; Wang, G.; Yang, J.; Yin, A.; Yu, X.; Zhao, M.; Zheng, H.; Accini, M., J.L.; Arcos, E.; Avendano, J.; Diaz Ruiz, J.E.A.; Garcia Ortiz, L.H.; Gonzalez, A.; Hernandez, T., E.; Higuera, J.D.; Malaver, N.; Molina de Salazar, D.I.; Rosero, R.; Terront, L., M.A.; Valderrama, C., L.; Valenzuela, A.; Vargas Alonso, R.D.; Villegas, I.; Yupanqui, H.; Bartaskova, D.; Barton, P.; Belobradkova, J.; Dohnalova, L.; Drasnar, T.; Ferkl, R.; Halciakova, K.; Klokocnikova, V.; Kovar, R.; Lastuvka, J.; Lukac, M.; Pesickova, S.; Peterka, K.; Pumprla, J.; Rychlik, I.; Saudek, F.; Tesar, V.; Valis, M.; Weiner, P.; Zemek, S.; Alamartine, E.; Borot, S.; Cariou, B.; Dussol, B.; Fauvel, J-P.; Gourdy, P.; Klein, A.; Le Meur, Y.; Penfornis, A.; Roussel, R.; Saulnier, P-J.; Thervet, E.; Zaoui, P.; Burst, V.; Faghih, M.; Faulmann, G.; Haller, H.; Jerwan-Keim, R.; Maxeiner, S.; Paschen, B.; Plassmann, G.; Rose, L.; Gonzalez Orellana, R.A.; Haase, F.P.; Moreira Diaz, J.P.; Ramirez Roca, L.A.; Sánchez Arenales, J.A.; Sanchez Polo, J.V.; Turcios Juarez, E.; Csecsei, G.; Csiky, B.; Danos, P.; Deak, L.; Dudas, M.; Harcsa, E.; Keltai, K.; Keresztesi, S.; Kiss, K.; Konyves, L.; Major, L.; Mileder, M.; Molnar, M.; Mucsi, J.; Oroszlan, T.; Ory, I.; Paragh, G.; Peterfai, E.; Petro, G.; Revesz, K.; Takacs, R.; Vangel, S.; Vasas, S.; Zsom, M.; Oomman, A.; Raju, S.B.; Dewan, D.; Fernando, M.E.; Gopalakrishnan, N.; Gracious, N.; Alva, H.; Jain, D.; Keshavamurthy, C.B.; Khullar, D.; Sahay, M.; Peringat, J.; Prasad, N.; Rao, K.S.; Reddy, S.; Melemadathil, S.; Sudhakar, B.; Vyasam, R.C.; Bonadonna, R.; Castellino, P.; Ceriello, A.; Chiovato, L.; De Cosmo, S.; De Nicola, L.; Derosa, G.; Di Carlo, A.; Di Cianni, G.; Frascà, G.; Fuiano, G.; Gambaro, G.; Garibotto, G.; Giorda, C.; Malberti, F.; Mandreoli, M.; Mannucci, E.; Orsi, E.; Piatti, P.; Santoro, D.; Sasso, F.C.; Serviddio, G.; Stella, A.; Trevisan, R.; Veronelli, A.M.; Zanoli, L.; Akiyama, H.; Aoki, H.; Asano, A.; Iitsuka, T.; Kajiyama, S.; Kashine, S.; Kawada, T.; Kodera, T.; Kono, H.; Koyama, K.; Kumeda, Y.; Miyauchi, S.; Mizuyama, K.; Niiya, T.; Oishi, H.; Ota, S.; Sakakibara, T.; Takai, M.; Tomonaga, O.; Tsujimoto, M.; Wada, T.; Wakasugi, M.; Wakida, Y.; Watanabe, T.; Yamada, M.; Yanagida, K.; Yanase, T.; Yumita, W.; Gaupsiene, E.; Kozloviene, D.; Navickas, A.; Urbanaviciene, E.; Abdul Ghani, R.; Abdul K., K.; Ali, N.; Che Y., M.D.; Gan, C.L.; Ismail, M.; Kong, W.Y.; Lam, S.W.; Lee, L.Y.; Lim, S.K.; Loh, C.L.; Manocha, A.B.; Ng, K.S.; Nik Ahmad, N.N.F.; Ratnasingam, V.; Shudim, S.S.B.; Vengadasalam, P.; Abraira M., L.D.; Alpizar Salazar, M.; Baas Cruz, J.; Burgos S., M.; Chevaile R., J.; Chew Wong, A.; Correa R., J.R.; Diaz E., T.; Enriquez S., F.E.; Flores L., F.; Flota C., L.F.; Frenk B., P.; Garcia Ballesteros, C.; Gomez R., J.D.; Herrera J., L.E.; Irizar S., S.S.; Jimenez F.F.; Laviada M., H.; Luna Ceballos, R.I.; Martin del C.B., B.; Morales F., G.; Moreno Loza, O.T.; Mustieles R., C.; Obrador V.G.; Orozco Castellanos, R.; Peralta C., J.; Reyes Rosano, M.A.; Rodriguez Pattzi, H.; Rosas G., J.; Rucker J., I.E.; Saavedra Sanchez, S.B.; Sanchez M., J.H.; Serrano S., P.; Tamayo y Orozco, J.A.; Tellez C., E.; Valdes Cepeda, A.; Venegas Carrillo, L.; Villagordoa Mesa, J.; Zamarripa Escobedo, R.; Baker, J.; Noonan, P.; Scott, R.; Walker, R.; Watson, E.; Williams, M.; Young, S.; Abejuela, Z.; Agra, J.; Aquitania, G.; Caringal, C.; Comia, R.S.; Delos Santos, L.; Gomez, O.; Jimeno, C.; Santos, F.; Tan, G.; Tolentino, M.; Yao, C.; Yap, Y.E.; Ygpuara, M.D.L.; Bijata-Bronisz, R.; Hotlos, L.; Januszewicz, A.; Kaczmarek, B.; Kaminska, A.; Lazuka, L.; Madej, A.; Mazur, S.; Mlodawska-Choluj, D.; Nowicki, M.; Orlowska-Kowalik, G.; Popenda, G.; Rewerska, B.; Sowinski, D.; Angelescu, L.M.; Anghel, V.; Avram, R-I.; Busegeanu, M-M.; Cif, A.; Cosma, D.; Crisan, C.; Demian, L.D.; Ferariu, I.E.; Halmagyi, I.; Hancu, N.; Munteanu, M.; Negru, D.; Onaca, A.G.; Petrica, L.; Popa, A.R.; Ranetti, A-E.; Serafinceanu, C.; Toarba, C.; Agafyina, A.; Barbarash, O.; Barysheva, O.; Chizhov, D.; Dobronravov, V.; Dreval, A.; Glinkina, I.; Grineva, E.; Khirmanov, V.; Kolmakova, E.; Koroleva, T.; Kvitkova, L.; Marasaev, V.; Mkrtumyan, A.; Morugova, T.; Nagibovich, G.; Nagibovich, O.; Nedogoda, S.; Osipova, I.; Raskina, T.; Samoylova, Y.; Sazonova, O.; Shamkhalova, M.; Shutemova, E.; Shwartz, Y.; Uriasyev, O.; Vorobyev, S.; Zateyshchikova, A.; Zateyshshikov, D.; Zykova, T.; Antic, S.; Djordjevic, M.; Kendereski, A.; Lalic, K.; Lalic, N.; Popovic-Radinovic, V.; Babikova, J.; Benusova, O.; Buganova, I.; Culak, J.; Dzupina, A.; Dzuponova, J.; Fulop, P.; Ilavska, A.; Martinka, E.; Ochodnicka, Z.; Pella, D.; Smatanova, I.; Ahmed, F.; Badat, A.; Breedt, J.; Distiller, L.; Govender, V.; Govender, R.; Joshi, M.; Jurgens, J.; Latiff, G.; Lombard, L.; Mookadam, M.; Ngcakani, N.; Nortje, H.; Oosthuizen, H.; Pillay-Ramaya, L.; Prozesky, H.; Reddy, J.; Rheeder, P.; Seeber, M.; Chae, D-W.; Cho, Y.M.; Jeong, I-K.; Kim, S.G.; Kim, Y.H.; Kwon, H-S.; Kwon, M.J.; Lee, B-W.; Lee, J.E.; Lee, M-K.; Nam, M-S.; Oh, K-H.; Park, C-Y.; Park, S-H.; Yoon, K.H.; Alvarez Garcia, P.; Asmarats Mercadal, L.; Barrios, C.; Cereto Castro, F.; Cigarran Guldris, S.; Dominguez L., M.; Egido de los Rios, J.; Fernandez F., G.; Galan S., A.; Garcia, I.; Gonzalez Martinez, F.J.; Jodar G., J.E.; Lopez M., M.; Malek Marin, T.; Morales Portillo, C.; Munar Vila, M.A.; Muñoz T., M.; Nieto Iglesias, J.; Pantoja Perez, J.; Perez Vera, M.; Portoles P., J.M.; Quesada Simón, M.A.; Simo C., R.; Soto Gonzalez, A.; Terns Riera, M.; Tinahones Madueno, F.J.; Velo Plaza, M.; Chang, C-T.; Chuang, L-M.; Hsia, T-L.; Hsieh, C-H.; Hwang, S-J.; Lin, C-C.; Lu, Y-C.; Sheu, W.H-H.; Barna, O.; Bilyk, S.D.; Botsyurko, V.; Dudar, I.; Fushtey, I.; Godlevska, O.; Golovchenko, O.; Gyrina, O.; Kazmirchuk, A.; Kolesnyk, M.; Komisarenko, I.; Korzh, O.; Kravchun, N.; Legun, O.; Mankovskyy, B.; Martynyuk, L.; Mostovoy, Y.; Pashkovska, N.; Pererva, L.; Pertseva, T.; Samoylov, O.; Smirnov, I.; Svyshchenko, Y.; Tomashkevych, H.; Topchii, I.; Tryshchuk, N.; Tseluyko, V.; Vizir, V.; Vlasenko, M.; Zlova, T.; Zub, L.; Abusnana, S.; Railey, M.; Abouglila, K.; Ainsworth, P.; Ali, Z.; Arutchelvam, V.; Barnard, M.; Bellary, S.; Davies, E.; Davies, M.; Davies, S.; Dawson, A.; El Kossi, M.; English, P.; Fraser, D.; Gnudi, L.; Gunstone, A.; Hall, T.; Hanif, W.; Jackson, A.; Johnson, A.; Joseph, F.; Krishnan, S.; Kumwenda, M.; MacDougall, I.; Nixon, P.; O’Hare, J.; Philip, S.; Ramtoola, S.; Saxena, M.; Sennik, D.; Simon, G.; Singh, B.; Stephens, J.; Strzelecka, A.; Symonds, R.; Turner, W.; Wahba, M.; Wakeling, J.; Wheeler, D.; Winocour, P.; Abdallah, J.; Abdullah, R.; Abramowitz, M.; Acosta, I.; Aiello, J.; Akright, L.; Akyea-Djamson, A.; Alappan, R.; Alicic, R.; Al-Karadsheh, A.; Allison, D.C.; Arauz-Pacheco, C.; Arfeen, S.; Arif, A.; Arvind, M.; Atray, N.; Awad, A.; Bakris, G.; Barnhill, P.; Barranco, E.; Barrera, C.; Beacom, M.; Behara, V.; Belo, D.; Bentley-Lewis, R.; Berenguer, R.; Bermudez, L.; Bernardo, M.; Biscoveanu, M.; Bowman-Stroud, C.; Brandon, D.; Brusco, O.; Busch, R.; Canaan, Y.; Chilito, A.; Christensen, T.; Christiano, C.; Christofides, E.; Chuateco, C.; Cohen, K.; Cohen, R.; Cohen-Stein, D.; Cook, C.; Coyne, D.; Daboul, N.; Darwish, R.; Daswani, A.; Deck, K.; Desouza, C.; Dev, D.; Dhillon, M.; Dua, S.; Eder, F.; Elosegui, A.M.; El-Shahawy, M.; Ervin, J.; Esquenazi, A.; Evans, J.; Fishbane, S.; Frias, J.; Galindo-Ramos, E.; Galphin, C.; Ghazi, A.; Gonzalez, E.; Gorson, D.; Gowda, A.; Greco, B.; Grubb, S.; Gulati, R.; Hammoud, J.; Handelsman, S.; Hartman, I.; Hershon, K.; Hiser, D.; Hon, G.; Jacob, R.; Jaime, M.; Jamal, A.; Kaupke, C.; Keightley, G.; Kern, E.; Khanna, R.; Khitan, Z.; Kim, S.; Kopyt, N.; Kovesdy, C.; Krishna, G.; Kropp, J.J.; Kumar, A.; Kumar, J.; Kumar, N.; Kusnir, J.; Lane, W.; Lawrence, M.; Lehrner, L.; Lentz, J.; Levinson, D.; Lewis, D.; Liss, K.; Maddux, A.; Maheshwari, H.; Mandayam, S.; Marar, I.; Mehta, B.; Middleton, J.; Mordujovich, J.; Moreda, R.; Moustafa, M.; Mujica Trenche, S.; Narayanan, M.; Narvarte, J.; Nassar, T.; Newman, G.; Nichol, B.; Nicol, P.; Nisnisan, J.; Nossuli, A.K.; Obialo, C.; Olelewe, S.; Oliver, M.; O’Shaughnessy, A.; Padron, J.; Pankhaniya, R.; Parker, R.; Patel, D.; Patel, G.; Patel, N.; Pavon, H.; Perez, A.; Perez, C.; Perlman, A.; Pettis, K.; Pharr, W.; Phillips, A.; Purighalla, R.; Quesada-Suarez, L.; Ranjan, R.; Rastogi, S.; Reddy, J.; Rendell, M.; Rich, L.; Robinson, M.; Rodriguez, H.; Rosas, S.; Saba, F.; Sankaram, R.; Sarin, R.; Schreiman, R.; Scott, D.; Sekkarie, M.; Sensenbrenner, J.; Shakeel, M.; Shanik, M.; Shaw, S.; Smith, S.; Solomon, R.; Sprague, A.; Spry, L.; Suchinda, P.; Sultan, S.; Surampudi, P.; Sussman, S.; Tan, A.; Terrelonge, A.; Thompson, M.; Trespalacios, F.; Trippe, B.; Trueba, P.; Twahirwa, M.; Updegrove, J.; Van Buren, P.; Vannorsdall, M.; Varghese, F.; Velasquez-Mieyer, P.; Ventrapragada, S.; Vukotic, G.; Wadud, K.; Warren, M.; Watson, H.; Watts, R.; Weiner, D.; Welker, J.; Welsh, J.; Williams, S.; Zaniewski-Singh, M. Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease. Stroke, 2021, 52(5), 1545-1556.
[http://dx.doi.org/10.1161/STROKEAHA.120.031623] [PMID: 33874750]

Dave, C.V.; Kim, S.C.; Goldfine, A.B.; Glynn, R.J.; Tong, A.; Patorno, E. Risk of cardiovascular outcomes in patients with type 2 diabetes after addition of SGLT2 inhibitors versus sulfonylureas to baseline GLP-1RA therapy. Circulation, 2021, 143(8), 770-779.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.120.047965] [PMID: 33302723]

Ong, H.T.; Teo, Y.H.; Teo, Y.N.; Syn, N.L.X.; Wee, C.F.; Leong, S.; Yip, A.S.Y.; See, R.M.; Ting, A.Z.H.; Chia, A.Z.Q.; Cheong, A.J.Y.; Tan, B.Y.Q.; Ho, J.S.Y.; Yeo, L.L.L.; Leow, A.S.T.; Yeo, T.C.; Wong, R.C.C.; Chai, P.; Kojodjojo, P.; Sia, C.H. Effects of sodium/glucose cotransporter inhibitors on atrial fibrillation and stroke: A meta-analysis. J. Stroke Cerebrovasc. Dis., 2022, 31(1)106159
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2021.106159] [PMID: 34689051]

Guo, M.; Ding, J.; Li, J.; Wang, J.; Zhang, T.; Liu, C.; Huang, W.; Long, Y.; Gao, C.; Xu, Y. SGLT2 inhibitors and risk of stroke in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Obes. Metab., 2018, 20(8), 1977-1982.
[http://dx.doi.org/10.1111/dom.13295] [PMID: 29573118]

Fitchett, D.; Inzucchi, S.E.; Cannon, C.P.; McGuire, D.K.; Scirica, B.M.; Johansen, O.E.; Sambevski, S.; Kaspers, S.; Pfarr, E.; George, J.T.; Zinman, B. Empagliflozin reduced mortality and hospitalization for heart failure across the spectrum of cardiovascular risk in the EMPA-REG outcome trial. Circulation, 2019, 139(11), 1384-1395.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.118.037778] [PMID: 30586757]

Zannad, F.; Ferreira, J.P.; Pocock, S.J.; Anker, S.D.; Butler, J.; Filippatos, G.; Brueckmann, M.; Ofstad, A.P.; Pfarr, E.; Jamal, W.; Packer, M. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials. Lancet, 2020, 396(10254), 819-829.
[http://dx.doi.org/10.1016/S0140-6736(20)31824-9] [PMID: 32877652]

Packer, M.; Anker, S.D.; Butler, J.; Filippatos, G.; Ferreira, J.P.; Pocock, S.J.; Sattar, N.; Brueckmann, M.; Jamal, W.; Cotton, D.; Iwata, T.; Zannad, F. Empagliflozin in patients with heart failure, reduced ejection fraction, and volume overload: EMPEROR-Reduced trial. J. Am. Coll. Cardiol., 2021, 77(11), 1381-1392.
[http://dx.doi.org/10.1016/j.jacc.2021.01.033] [PMID: 33736819]

Anker, S.D.; Butler, J.; Filippatos, G.; Ferreira, J.P.; Bocchi, E.; Böhm, M.; Brunner-La Rocca, H.P.; Choi, D.J.; Chopra, V.; Chuquiure-Valenzuela, E.; Giannetti, N.; Gomez-Mesa, J.E.; Janssens, S.; Januzzi, J.L.; Gonzalez-Juanatey, J.R.; Merkely, B.; Nicholls, S.J.; Perrone, S.V.; Piña, I.L.; Ponikowski, P.; Senni, M.; Sim, D.; Spinar, J.; Squire, I.; Taddei, S.; Tsutsui, H.; Verma, S.; Vinereanu, D.; Zhang, J.; Carson, P.; Lam, C.S.P.; Marx, N.; Zeller, C.; Sattar, N.; Jamal, W.; Schnaidt, S.; Schnee, J.M.; Brueckmann, M.; Pocock, S.J.; Zannad, F.; Packer, M. Empagliflozin in heart failure with a preserved ejection fraction. N. Engl. J. Med., 2021, 385(16), 1451-1461.
[http://dx.doi.org/10.1056/NEJMoa2107038] [PMID: 34449189]

Ptaszynska, A.; Cohen, S.M.; Messing, E.M.; Reilly, T.P.; Johnsson, E.; Johnsson, K. Assessing bladder cancer risk in type 2 diabetes clinical trials: The dapagliflozin drug development program as a “case study.”. Diabetes Ther., 2015, 6(3), 357-375.
[http://dx.doi.org/10.1007/s13300-015-0128-9] [PMID: 26323372]

Gallwitz, B. Clinical use of DPP-4 inhibitors. Front. Endocrinol., 2019, 10, 389.
[http://dx.doi.org/10.3389/fendo.2019.00389] [PMID: 31275246]

Unnikrishnan, A.G.; Kalra, S.; Purandare, V.; Vasnawala, H. Genital infections with sodium glucose cotransporter-2 inhibitors: Occurrence and management in patients with type 2 diabetes mellitus. Indian J. Endocrinol. Metab., 2018, 22(6), 837-842.
[http://dx.doi.org/10.4103/ijem.IJEM_159_17] [PMID: 30766827]

Hu, Y.; Bai, Z.; Tang, Y.; Liu, R.; Zhao, B.; Gong, J. Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: A pharmacovigilance study with data from the U.S. FDA adverse event reporting system. J. Diabetes Res., 2020, •••3695101

Kluger, A.Y.; Tecson, K.M.; Lee, A.Y.; Lerma, E.V.; Rangaswami, J.; Lepor, N.E.; Cobble, M.E.; McCullough, P.A. Class effects of SGLT2 inhibitors on cardiorenal outcomes. Cardiovasc. Diabetol., 2019, 18(1), 99.
[http://dx.doi.org/10.1186/s12933-019-0903-4] [PMID: 31382965]